Transcarent

Denver, CO · Founded 2020 · Privately Held (backing)

Developer of a consumer-directed health and care platform designed to facilitate improved outcomes and cost-effective decisions. Transcarent is based in Denver, CO and was founded in 2020. It was valued at $2.7 billion at its later-stage round in Apr 2025, the last priced event on record. It has raised $905 million across 1 recorded round; the latest was a $481 million later-stage round in Apr 2025.

PMV mark · valuation
$2.7B
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$905.0M
Last round
Later Stage VC
Apr 2025
What is Transcarent worth?
$2.7BPrivateMarketView mark · Oct 2026

Valued at $2.7B at its later-stage round, Apr 2025. Nothing has traded since.

Free account
More of Transcarent with a free account
  • ·The complete investor list: 23 names
  • ·Watch Transcarent: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Transcarent funding history

1 rounds
DateRoundRaisedPost-money
Apr 2025Later Stage VC$481.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Transcarent valuation

Transcarent was valued at $2.7 billion at its later-stage round in Apr 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Transcarent raised?

Transcarent has raised $905 million in total; 1 of its rounds is on record. The largest on record was a $481 million later-stage round in Apr 2025.

Transcarent has filed 1 Form D with the SEC, most recently in Apr 2025 ($481 million sold to 33 investors).

How Transcarent's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Transcarent, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Transcarent

What is Transcarent worth?
Transcarent is valued at $2.7B as of Oct 2026. Valued at $2.7B at its later-stage round, Apr 2025. Nothing has traded since.
How much has Transcarent raised?
Transcarent has raised $905.0M in total funding across 1 recorded rounds.
When did Transcarent last raise?
Transcarent last raised in Apr 2025 (Later Stage VC), raising $481.0M.